Valduga F - Search Results

1

Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone.

Caffo O, Sava T, Comploj E, Giampaolo MA, Segati R, Valduga F, Cetto G, Galligioni E. Caffo O, et al. Among authors: valduga f. Urol Oncol. 2010 Mar-Apr;28(2):152-6. doi: 10.1016/j.urolonc.2008.07.033. Epub 2008 Oct 10. Urol Oncol. 2010. PMID: 18848786 Clinical Trial.

2

Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial.

Caffo O, Sava T, Comploj E, Fariello A, Zustovich F, Segati R, Sacco C, Valduga F, Cetto G, Galligioni E. Caffo O, et al. Among authors: valduga f. BJU Int. 2008 Nov;102(9):1080-5. doi: 10.1111/j.1464-410X.2008.07779.x. Epub 2008 May 15. BJU Int. 2008. PMID: 18485028 Clinical Trial.

3

Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: assessment of clinical outcomes and predictive factors.

Caffo O, Pappagallo G, Brugnara S, Caldara A, di Pasquale MC, Ferro A, Frisinghelli M, Murgia V, Russo LM, Soini B, Valduga F, Veccia A, Galligioni E. Caffo O, et al. Among authors: valduga f. Urology. 2012 Mar;79(3):644-9. doi: 10.1016/j.urology.2011.11.043. Urology. 2012. PMID: 22386418

4

Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer.

Cappuzzo F, Mazzoni F, Gennari A, Donati S, Salvadori B, Orlandini C, Cetto GL, Molino A, Galligioni E, Mansutti M, Tumolo S, Lucentini A, Valduga F, Bartolini S, Crinò L, Conte PF. Cappuzzo F, et al. Among authors: valduga f. Br J Cancer. 2004 Jan 12;90(1):31-5. doi: 10.1038/sj.bjc.6601518. Br J Cancer. 2004. PMID: 14710202 Free PMC article. Clinical Trial.

5

Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.

Caffo O, Fellin G, Graffer U, Valduga F, Bolner A, Luciani L, Tomio L, Galligioni E. Caffo O, et al. Among authors: valduga f. Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1310-6. doi: 10.1016/s0360-3016(03)00763-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 14630267 Clinical Trial.

6

A phase II study of liposomal doxorubicin in recurrent epithelial ovarian carcinoma.

Arcuri C, Sorio R, Tognon G, Gambino A, Scalone S, Lucenti A, Caffo O, Valduga F, Arisi E, Galligioni E. Arcuri C, et al. Among authors: valduga f. Tumori. 2004 Nov-Dec;90(6):556-61. doi: 10.1177/030089160409000604. Tumori. 2004. PMID: 15762356 Clinical Trial.

7

Pain and quality of life after surgery for breast cancer.

Caffo O, Amichetti M, Ferro A, Lucenti A, Valduga F, Galligioni E. Caffo O, et al. Among authors: valduga f. Breast Cancer Res Treat. 2003 Jul;80(1):39-48. doi: 10.1023/A:1024435101619. Breast Cancer Res Treat. 2003. PMID: 12889597

8

Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre.

Dipasquale M, Murgia V, Veccia A, Brugnara S, Caldara A, Ferro A, Frisinghelli M, Maines F, Trentin C, Valduga F, Caffo O. Dipasquale M, et al. Among authors: valduga f. Anticancer Drugs. 2017 Jul;28(6):654-659. doi: 10.1097/CAD.0000000000000482. Anticancer Drugs. 2017. PMID: 28252532

9

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience.

Galligioni E, Berloffa F, Caffo O, Tonazzolli G, Ambrosini G, Valduga F, Eccher C, Ferro A, Forti S. Galligioni E, et al. Among authors: valduga f. Ann Oncol. 2009 Feb;20(2):349-52. doi: 10.1093/annonc/mdn567. Epub 2008 Aug 20. Ann Oncol. 2009. PMID: 18718889 Free article.

10

Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience.

De Giorgi U, Rosti G, Papiani G, Aieta M, Fochessati F, Paoluzzi L, Valduga F, Marangolo M. De Giorgi U, et al. Among authors: valduga f. Am J Clin Oncol. 2004 Oct;27(5):457-60. doi: 10.1097/01.coc.0000128727.40450.9e. Am J Clin Oncol. 2004. PMID: 15596910 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters